Inventor · disambiguated record
Pasi Koskimies
Also filed as: KOSKIMIES PASI
15 granted patents·6 pending applications·9 citations·filing 2004–2025
86Inventor score
Files withFORENDO PHARMA LTD9SOLVAY PHARM BV5MESSINGER JOSEF4ORGANON R&D FINLAND LTD2ABBOTT PRODUCTS GMBH1
Top patents by PatentIndex Score
21 records- 0178US10717761B2Therapeutically active steroidal derivativesFORENDO PHARMA LTD·Filed 2018·Granted Jul 21, 2020·1 cites·20 claims
- 0278US2024309043A1Therapeutically active steroidal derivativesORGANON R&D FINLAND LTD·Filed 2024·Application pending·0 cites
- 0376US11254703B2Therapeutically active steroidal derivativesFORENDO PHARMA LTD·Filed 2020·Granted Feb 22, 2022·1 cites·18 claims
- 0473US8030298B217β-HSD1 and STS inhibitorsABBOTT PRODUCTS GMBH·Filed 2006·Granted Oct 4, 2011·3 cites·23 claims
- 0573US2025263431A1Therapeutically active steroidal derivativesORGANON R&D FINLAND LTD·Filed 2025·Application pending·0 cites
- 0670US8288367B2Substituted estratriene derivatives as 17BETA HSD inhibitorsMESSINGER JOSEF·Filed 2007·Granted Oct 16, 2012·2 cites·34 claims
- 0768US2022127303A1Therapeutically active steroidal derivativesFORENDO PHARMA LTD·Filed 2022·Application pending·0 cites
- 0859US7524853B2Compounds and their use in therapySOLVAY PHARM BV·Filed 2004·Granted Apr 28, 2009·1 cites·40 claims
- 0951US10626140B2Prodrugs of 17β-HSD1-inhibitorsFORENDO PHARMA LTD·Filed 2015·Granted Apr 21, 2020·0 cites·12 claims
- 1051US7754709B2Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compoundsSOLVAY PHARM BV·Filed 2004·Granted Jul 13, 2010·1 cites·3 claims
- 1148US2022041647A1Estra-1,3,5(10)-triene compounds condensed in position 16(17) with a pyrazole ring as inhibitors of 17-hsd1FORENDO PHARMA LTD·Filed 2019·Application pending·0 cites
- 1247US2008103131A1Therapeutically Active Thiophenepyrimidinone Compounds and Their UseSOLVAY PHARM BV·Filed 2007·Application pending·0 cites
- 1344US10377791B2Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydroxysteroid dehydrogenase, type 1FORENDO PHARMA LTD·Filed 2014·Granted Aug 13, 2019·0 cites·16 claims
- 1443US9850272B2Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1FORENDO PHARMA LTD·Filed 2014·Granted Dec 26, 2017·0 cites·20 claims
- 1543US9663549B2Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17β-hydroxysteroid dehydrogenaseFORENDO PHARMA LTD·Filed 2014·Granted May 30, 2017·0 cites·24 claims
- 1640US8435973B217-beta HSD1 and STS inhibitorsMESSINGER JOSEF·Filed 2010·Granted May 7, 2013·0 cites·21 claims
- 1740US8080540B2Therapeutically active triazoles and their useMESSINGER JOSEF·Filed 2007·Granted Dec 20, 2011·0 cites·22 claims
- 1837US8088758B217β-hydroxysteroid dehydrogenase type I inhibitorsMESSINGER JOSEF·Filed 2004·Granted Jan 3, 2012·0 cites·41 claims
- 1936US7465739B2Compounds and their use in therapySOLVAY PHARM BV·Filed 2004·Granted Dec 16, 2008·0 cites·41 claims
- 2036US2010249106A1Methods of Making and Using Therapeutically Active Thiophenepyrimidinone CompoundsSOLVAY PHARM BV·Filed 2010·Application pending·0 cites
- 2133US10413557B2Prodrugs of 17.BETA.-HSD1-inhibitorsFORENDO PHARMA LTD·Filed 2015·Granted Sep 17, 2019·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Pasi Koskimies files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →